Header Logo

Connection

Philip Bonomi to Receptors, TNF-Related Apoptosis-Inducing Ligand

This is a "connection" page, showing publications Philip Bonomi has written about Receptors, TNF-Related Apoptosis-Inducing Ligand.
  1. Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer. Lung Cancer. 2008 Jul; 61(1):82-90.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.